PPARA and metabolic syndrome: It is nevertheless interesting to note that a certain number of physiological effects observed during our first study, yet less pronounced, are still analogous to the expected effects induced by endogenous/exogenous activation of PPARα in the context of obesity (i.e., reduced dyslipidemia, lesser inflammation, and decreased insulin resistance) [20,43].